Abstract:Retinal vein occlusion-induced macular edema(RVO-ME)is a severe complication of retinal vein occlusion, known for its challenging treatment, persistence, and tendency to recur. Recent studies have demonstrated that combined therapy offers advantages over single therapy, effectively reducing macular edema, enhancing visual function, decreasing the frequency of treatments, lowering overall costs, and easing the patient's burden. This approach addresses the limitations of single treatment methods and has garnered significant clinical interest. This article reviews the current status and future prospects of combined treatments for RVO-ME.
